Moderna
MRNA
#1709
Rank
โ‚น815.83 B
Marketcap
โ‚น2,110
Share price
-1.89%
Change (1 day)
-75.60%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -โ‚น301.57 Billion

According to Moderna 's latest financial reports the company's current earnings are โ‚น3.19 Billion. , an increase over its 2023 earnings that were of -โ‚น333.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚น305.92 Billion-8.22%
2023 -โ‚น333.33 Billion-140.65%
2022 โ‚น819.98 B-27.81%
2021 โ‚น1.135 T-1911.15%
2020 -โ‚น62.72 Billion44.7%
2019 -โ‚น43.34 Billion28.63%
2018 -โ‚น33.7 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น3.95 Billion-98.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.810 T-691.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น3.57 Billion-98.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น20.11 Billion-93.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.164 T-480.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-โ‚น51.25 Billion-83.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.489 T-586.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น10.05 Billion-96.72%๐Ÿ‡บ๐Ÿ‡ธ USA